Modern Diagnostic and Research Centre is opening its share offer on the BSE SME platform, aiming to raise roughly Rs 37 crore.
Key IPO Details
- Price band: Rs 85‑Rs 90 per share
- Lot size: 1,600 shares (minimum 2 lots for retail)
- Investment needed: Rs 1.44 lac – Rs 2.88 lac (depending on price)
- Subscription window: opens Wednesday, closes 2 Jan
- Allotment: expected 5 Jan; listing: 7 Jan
Company Snapshot
Founded in 1985, Modern Diagnostic runs 21 centres across eight states, offering pathology, molecular tests, radiology (MRI, CT) and home‑sample collection.
Use of IPO Proceeds
- Buy new medical equipment for labs and diagnostic centres
- Support working capital needs
- Partially repay existing loans to strengthen the balance sheet
Recent Financial Performance
- FY 2025 revenue: Rs 78.8 crore (up 15% YoY)
- Profit after tax: Rs 8.97 crore (up 55%)
- Assets: Rs 77.86 crore; Net worth: Rs 23.72 crore
- Borrowings: Rs 30.38 crore, to be reduced with IPO funds
Allocation Overview
- ~47% for qualified institutional buyers
- ~33% for retail investors
- Remaining for non‑institutional investors and anchor participants
- Anchor investors already have Rs 10.45 crore of shares, showing institutional interest
Why Retail Investors Might Care
The healthcare diagnostics sector is expected to grow steadily, and Modern Diagnostic’s long‑standing presence could make the IPO an attractive entry point. With a modest premium indicated in the grey market (around 12%), the issue offers a chance to join a business that is expanding its equipment base and reducing debt.
Disclaimer
Remember, this is just an overview, not a recommendation. Do your own research and consider your risk tolerance before investing.